Oral interleukin-23-receptor antagonist peptide shows greater efficacy than placebo for plaque psoriasis
For patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published in the Feb. 8 issue of the New England ...
Feb 8, 2024
0
0